Abstract

The edible leaves of the mulberry (Morus alba L.) plant are used worldwide. They contain abundant polyphenolic compounds with strong anticancer properties. We previously revealed that apoptosis was mediated in p53-negative Hep3B cells, and mulberry leaf polyphenol extract (MLPE) induced autophagy in p53-transfected Hep3B cells. However, how this autophagy is induced by p53 in human hepatoma HepG2 (p53 wild type) cells remains unclear. In the current study, MLPE induced autophagy, as demonstrated by enhanced acidic vesicular organelle staining, by upregulating beclin-1, increasing LC3-II conversion, and phosphorylating AMPK. In HepG2 cells, these processes were associated with p53. Western blot also revealed phosphatidylinositol-3 kinase (PI3K), p-AKT, and fatty acid synthase (FASN) suppression in MLPE-treated cells. Moreover, treatment with the p53 inhibitor pifithrin-α (PFT-α) inhibited autophagy and increased apoptotic response in MLPE-treated HepG2 cells. PFT-α treatment also reversed MLPE-induced PI3K, p-AKT, and FASN suppression. Thus, co-treatment with MLPE and PFT-α significantly increased caspase-3, caspase-8, and cytochrome c release, indicating that p53 deficiency caused the apoptosis. In addition, rutin, a bioactive polyphenol in MLPE, may affect autophagy in HepG2 cells. This study demonstrates that MLPE is a potential anticancer agent targeting autophagy and apoptosis in cells with p53 status. Moreover, this work provides insight into the mechanism of p53 action in MLPE-induced cytotoxicity in hepatocellular carcinoma.

Highlights

  • We previously reported that apoptosis was induced by mulberry leaf polyphenol extract (MLPE) in Hep3B cells via a pathway independent of p53; MLPE induced autophagy in Hep3B cells transfected with p53 [16]

  • We investigated whether p53-regulated AMPK/fatty acid synthase (FASN) expression is associated with MLPEinduced autophagy

  • We previously demonstrated that MLPE induced apoptosis and autophagy in p53-negative and p53-positive (p53-transfected) Hep3B cells, respectively [16]

Read more

Summary

Introduction

Hepatocellular carcinoma (HCC) is a major cancer worldwide [1]. HCC risk factors include human immunodeficiency virus, hepatitis B virus, alcoholic liver disease, and nonalcoholic fatty liver disease [2]. Treatment options include surgical resection, chemotherapy, and radiotherapy [3]. Recent studies have shown that surgical resection and transplantation remain the curative standard of care for early-stage patients. The effects of immunotherapy and personalized biomolecule signatures on improvement of HCC survival rate provide a stronger strategy to tackle this disease [4].

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call